Watch Demo

The Netherlands Healthcare Industry Outlook 2022 - 2026

See how the Netherlands Healthcare performed compared to key markets such as the United States, Switzerland and Norway.

Key Market Indicators

Dutch Health Expenditure is set to reach $7,200 PPP Per Capita by 2026 from $6,490 PPP Per Capita in 2021, growing 1.6% year on year on average. Since 2005, Dutch demand increased 3.8% year on year. The country ranked number 7 in 2021, Denmark overtook at $6,490 PPP Per Capita. Switzerland, Norway and Germany respectively were numbers 2, 3 and 4 in this ranking.

The Netherlands Healthcare Market Data and Forecasts

What is the size of the Dutch Healthcare Market in 2022?

Medical Wadding Gauze Dressings Market Size Value Per Capita in the Netherlands
  • US Dollars Per Capita
  • 2009 to 2021
  • ReportLinker Research
Pacemakers and Hearing Aids Market Size Volume Per Capita in the Netherlands
  • Units Per Capita
  • 2009 to 2021
  • ReportLinker Research
More in Healthcare Industry in major countries

Purchase Reports from Reputable Market Research Publishers

Influenza A Virus, H7N9 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update New
Influenza A Virus, H7N9 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
  • $ 2000
  • December 2022
  • 60 pages
Influenza A Virus, H5N1 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Influenza A Virus, H5N1 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
  • $ 2000
  • May 2022
  • 104 pages
Influenza A Virus, H3N2 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Influenza A Virus, H3N2 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
  • $ 2000
  • April 2022
  • 123 pages
Influenza A Virus, H1N1 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Influenza A Virus, H1N1 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
  • $ 2500
  • May 2022
  • 201 pages
Progressive Supranuclear Palsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update New
Progressive Supranuclear Palsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
  • $ 2000
  • November 2022
  • 85 pages
Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) - Drugs in Development, 2021
Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) - Drugs in Development, 2021
  • $ 2000
  • December 2021
  • 114 pages
Influenza A Virus, H3N2 Subtype Infections (Infectious Disease) - Drugs In Development, 2021
Influenza A Virus, H3N2 Subtype Infections (Infectious Disease) - Drugs In Development, 2021
  • $ 2000
  • July 2021
  • 173 pages
Progressive Supranuclear Palsy (Central Nervous System) - Drugs in Development, 2021
Progressive Supranuclear Palsy (Central Nervous System) - Drugs in Development, 2021
  • $ 2000
  • November 2021
  • 136 pages
Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) - Drugs In Development, 2021
Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) - Drugs In Development, 2021
  • $ 2000
  • July 2021
  • 178 pages
Mammography Market Size, Share & Trends Analysis Report By Product, By Technology, By Region And Segment Forecasts, 2022 - 2030
Mammography Market Size, Share & Trends Analysis Report By Product, By Technology, By Region And Segment Forecasts, 2022 - 2030
  • $ 5950
  • June 2022
  • 90 pages